查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370515

靜脈 (IV) 布洛芬市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Intravenous (IV) Ibuprofen Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

概要

市場概況：

2022年，全球靜脈注射（IV）布洛芬市場規模達63億美元。展望未來，IMARC Group預計到2028年市場規模將達到102億美元，2023-2028年年複合成長率（CAGR）為7.78% 。

布洛芬屬於非類固醇類抗發炎藥 (NSAID)，用於治療發炎、疼痛和發燒。它抑制合成前列腺素 (PG) 所需的環氧合酶 COZ-1 和 COX-2。靜脈注射 (IV) 布洛芬可單獨使用或與其他藥物一起使用，以緩解輕度至重度不適。它被直接注射到靜脈中，以阻止身體產生某些引起發炎的天然物質。它具有出色的安全性，有助於減少麻醉鎮痛需求並降低疼痛程度。靜脈注射布洛芬也有助於改善疼痛控制並減少骨科和腹部手術中鴉片類藥物的使用以及發燒。

靜脈（IV）布洛芬市場趨勢：

全球範圍內老年人口的穩定成長以及關節炎、心血管疾病 (CVD) 和癌症患病率的不斷上升正在為市場創造積極的前景。與此一致的是，用於管理和治療發炎性疾病、類風濕性疾病、輕度至中度疼痛、發燒、經痛和骨關節炎的產品的廣泛採用有利於市場成長。此外，繁忙的工作日程和不健康的生活方式，以及隨之而來的體力活動和適當營養的減少，導致慢性病的發病率上升，這是另一個促進生長的因素。除此之外，兒科治療輕度發燒、牙痛、胃腸道疼痛和動脈導管的產品使用量不斷增加，也推動了市場成長。此外，靜脈注射布洛芬用於緩解肌肉或風濕疼痛、背痛、神經痛、扭傷、拉傷、運動傷害和肌肉骨骼疾病，這促進了市場成長。此外，骨科患者在膝關節或髖關節置換手術後對靜脈注射布洛芬的需求不斷增加，以減輕疼痛和嗎啡的使用，這對市場成長產生了積極影響。其他因素，包括醫療保健基礎設施的顯著改善、個人健康意識的增強以及消費者支出能力的提高，預計將推動市場成長。

本報告回答的關鍵問題

  • 2022年全球靜脈（IV）布洛芬市場規模？
  • 2023-2028年全球靜脈（IV）布洛芬市場的預期成長率是多少？
  • 推動全球靜脈（IV）布洛芬市場的關鍵因素是什麼？
  • COVID-19 對全球靜脈 (IV) 布洛芬市場有何影響？
  • 根據適應症，全球靜脈 (IV) 布洛芬市場的細分如何？
  • 按年齡層別分類，全球靜脈 (IV) 布洛芬市場的細分如何？
  • 全球靜脈（IV）布洛芬市場的主要區域有哪些？
  • 全球靜脈 (IV) 布洛芬市場的主要參與者/公司有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球靜脈 (IV) 布洛芬市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：依產品劑量分類的市場

  • 100 毫克劑量
    • 市場走向
    • 市場預測
  • 200 毫克劑量
    • 市場走向
    • 市場預測
  • 400 毫克劑量
    • 市場走向
    • 市場預測
  • 800 毫克劑量
    • 市場走向
    • 市場預測

第 7 章：按跡象分類的市場

  • 疼痛/炎症
    • 市場走向
    • 市場預測
  • 發燒
    • 市場走向
    • 市場預測

第 8 章：按年齡層別分類的市場區隔

  • 兒科
    • 市場走向
    • 市場預測
  • 成年人
    • 市場走向
    • 市場預測

第 9 章：按地區分類的市場區隔

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 10 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：價格分析

第14章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Cumberland Pharmaceuticals Inc.
    • Hyloris Pharmaceuticals SA
    • Recordati Rare Diseases Inc.
    • VALMOR Laboratories CA
    • Xgen Pharmaceuticals Djb Inc.
Product Code: SR112023A6440

Abstract

Market Overview:

The global intravenous (IV) ibuprofen market size reached US$ 6.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.2 Billion by 2028, exhibiting a growth rate (CAGR) of 7.78% during 2023-2028.

Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class used to treat inflammation, pain, and fever. It inhibits cyclooxygenase COZ-1 and COX-2 enzymes that are required for the synthesis of prostaglandins (PG). Intravenous (IV) ibuprofen is used alone or with other medicines to relieve mild to severe discomfort. It is injected directly into the vein to block the body's production of certain natural substances that cause inflammation. It helps to reduce narcotic analgesic requirements and lower pain levels with an excellent safety profile. IV ibuprofen also aids in improving pain control and reducing the usage of opioid drugs in orthopedic and abdominal surgeries and fever.

Intravenous (IV) Ibuprofen Market Trends:

The steadily rising geriatric population and the increasing prevalence of arthritis, cardiovascular diseases (CVDs), and cancer across the globe are creating a positive outlook for the market. In line with this, the widespread product adoption to manage and treat inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis is favoring the market growth. Moreover, hectic working schedules and unhealthy lifestyles, along with a consequent decline in physical activity and proper nutrition, have led to a rise in the incidences of chronic diseases, which is acting as another growth-inducing factor. Apart from this, the increasing product utilization to treat mild fever, dental pain, gastrointestinal pain, and ductus arteriosus in pediatrics is providing an impetus to the market growth. Moreover, IV ibuprofen is employed to relieve muscle or rheumatic pain, backache, neuralgia, sprains, strains, sports injuries, and musculoskeletal diseases, which is facilitating the market growth. Furthermore, the increasing demand for IV ibuprofen in orthopedic patients post knee or hip replacement surgeries to reduce pain and morphine use is positively influencing the market growth. Other factors, including significant improvements in the healthcare infrastructure, growing health consciousness among individuals, and the rising expenditure capacities of consumers, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global intravenous (IV) ibuprofen market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product dose, indication and age group.

Breakup by Product Dose:

100 Mg Dose

200 Mg Dose

400 Mg Dose

800 Mg Dose

Breakup by Indication:

Pain/Inflammatory

Fever

Breakup by Age Group:

Pediatrics

Adults

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.

Key Questions Answered in This Report

  • 1. What was the size of the global Intravenous (IV) ibuprofen market in 2022?
  • 2. What is the expected growth rate of the global Intravenous (IV) ibuprofen market during 2023-2028?
  • 3. What are the key factors driving the global Intravenous (IV) ibuprofen market?
  • 4. What has been the impact of COVID-19 on the global Intravenous (IV) ibuprofen market?
  • 5. What is the breakup of the global Intravenous (IV) ibuprofen market based on the indication?
  • 6. What is the breakup of the global Intravenous (IV) ibuprofen market based on the age group?
  • 7. What are the key regions in the global Intravenous (IV) ibuprofen market?
  • 8. Who are the key players/companies in the global Intravenous (IV) ibuprofen market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Ibuprofen Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Dose

  • 6.1 100 Mg Dose
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 200 Mg Dose
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 400 Mg Dose
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 800 Mg Dose
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Pain/Inflammatory
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fever
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age Group

  • 8.1 Pediatrics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Adults
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Cumberland Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hyloris Pharmaceuticals SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Recordati Rare Diseases Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 VALMOR Laboratories CA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Xgen Pharmaceuticals Djb Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio

List of Figures

  • Figure 1: Global: Intravenous Ibuprofen Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Ibuprofen Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Intravenous Ibuprofen Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Intravenous Ibuprofen Market: Breakup by Product Dose (in %), 2022
  • Figure 5: Global: Intravenous Ibuprofen Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Intravenous Ibuprofen Market: Breakup by Age Group (in %), 2022
  • Figure 7: Global: Intravenous Ibuprofen Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Intravenous Ibuprofen (100 Mg Dose) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Intravenous Ibuprofen (100 Mg Dose) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Intravenous Ibuprofen (200 Mg Dose) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Intravenous Ibuprofen (200 Mg Dose) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Intravenous Ibuprofen (400 Mg Dose) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Intravenous Ibuprofen (400 Mg Dose) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Intravenous Ibuprofen (800 Mg Dose) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Intravenous Ibuprofen (800 Mg Dose) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Intravenous Ibuprofen (Fever) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Intravenous Ibuprofen (Fever) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Intravenous Ibuprofen (Pediatrics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Intravenous Ibuprofen (Pediatrics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Intravenous Ibuprofen (Adults) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Intravenous Ibuprofen (Adults) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: North America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: North America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: United States: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: United States: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Canada: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Canada: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Asia-Pacific: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Asia-Pacific: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: China: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: China: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Japan: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Japan: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: India: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: India: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: South Korea: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: South Korea: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Australia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Australia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Indonesia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Indonesia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Europe: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Europe: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Germany: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Germany: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: France: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: France: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United Kingdom: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United Kingdom: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Italy: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Italy: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Spain: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Spain: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Russia: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Russia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Latin America: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Latin America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Brazil: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Brazil: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Mexico: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Mexico: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Middle East and Africa: Intravenous Ibuprofen Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Middle East and Africa: Intravenous Ibuprofen Market: Breakup by Country (in %), 2022
  • Figure 72: Middle East and Africa: Intravenous Ibuprofen Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Global: Intravenous Ibuprofen Industry: SWOT Analysis
  • Figure 74: Global: Intravenous Ibuprofen Industry: Value Chain Analysis
  • Figure 75: Global: Intravenous Ibuprofen Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Ibuprofen Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Intravenous Ibuprofen Market Forecast: Breakup by Product Dose (in Million US$), 2023-2028
  • Table 3: Global: Intravenous Ibuprofen Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Intravenous Ibuprofen Market Forecast: Breakup by Age Group (in Million US$), 2023-2028
  • Table 5: Global: Intravenous Ibuprofen Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Intravenous Ibuprofen Market: Competitive Structure
  • Table 7: Global: Intravenous Ibuprofen Market: Key Players